![Cléa Rosenfeld](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cléa Rosenfeld
Investor Relations Contact at ONCIMMUNE HOLDINGS PLC
Cléa Rosenfeld active positions
Companies | Position | Start | End |
---|---|---|---|
ONCIMMUNE HOLDINGS PLC | Investor Relations Contact | 2019-06-30 | - |
Career history of Cléa Rosenfeld
Former positions of Cléa Rosenfeld
Companies | Position | Start | End |
---|---|---|---|
Shire Plc /Old/
![]() Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Public Communications Contact | - | 2008-05-22 |
SPECTRIS PLC | Investor Relations Contact | - | - |
SHIRE | Public Communications Contact | 2009-07-26 | - |
Statistics
International
United Kingdom | 4 |
Ireland | 2 |
Operational
Public Communications Contact | 2 |
Investor Relations Contact | 2 |
Sectoral
Health Technology | 3 |
Commercial Services | 2 |
Producer Manufacturing | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
SPECTRIS PLC | Producer Manufacturing |
ONCIMMUNE HOLDINGS PLC | Health Technology |
Private companies | 2 |
---|---|
Shire Plc /Old/
![]() Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
Shire Plc
![]() Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Cléa Rosenfeld
- Experience